Advertisement
Berita Forex
Asian Markets Mostly Higher On Global Cues
Asian stock markets are trading mostly higher on Tuesday, following the positive cues from global markets overnight, as traders remain cautious while they await the release of the U.S. inflation data later in the day for more clues about the Fed's interest rate move at the upcoming policy meeting later this month. The optimism about a slowdown in inflation triggered some buying in the market.
RTTNews |
960 hari yang lalu
Indian Shares Set To Follow Global Peers Higher
Indian shares are seen opening higher on Tuesday, mirroring positive cues from global markets.
RTTNews
|
960 hari yang lalu
Japanese Market Modestly Higher
The Japanese stock market is modestly higher in choppy trading on Tuesday, extending the gains in the previous three sessions, with the Nikkei 225 moving above the 28,600 level, following the broadly positive cues from global markets overnight, even as traders remain concerned over the outlook for interest rates and rising inflation.
RTTNews
|
960 hari yang lalu
Australian Market Modestly Higher
The Australian stock market is modestly higher on Tuesday, extending the gains in the previous three sessions, with the benchmark S&P/ASX 200 a tad below the 7,000 mark, following the broadly positive cues from global markets overnight, with strength across most sectors, led by energy stocks amid spiking crude oil prices.
RTTNews
|
960 hari yang lalu
TSX Extends Gains To 4th Straight Session, Rises More Than 1%
Canadian stocks ended on a bright note on Monday, extending gains to a fourth straight session, as optimism about a slowdown in U.S. inflation triggered some strong buying in the market.
RTTNews
|
961 hari yang lalu
Dollar Extends Weakness Against Rivals Ahead Of Inflation Data
The U.S. dollar drifted lower against most of its major counterparts on Monday, extending its slide from the previous session, weighed down by very hawkish comments from the European Central Bank.
RTTNews
|
961 hari yang lalu
Swiss Market Ends On Firm Note For 2nd Straight Day
The Switzerland stock market eased a bit after opening modestly up Monday morning, but recovered swiftly and kept edging higher as the session progressed to eventually close on a firm note.
RTTNews
|
961 hari yang lalu
more news
European Stocks End Higher Again As Risk Sentiment Improves
European stocks closed higher on Monday, extending recent gains, amid improved risk sentiment despite aggressive policy stance by major central banks and the likely impact on global growth.
RTTNews
|
961 hari yang lalu
Canadian Market Extending Recent Gains; Energy, Financial Stocks Move Up
The Canadian market is up firmly in positive territory around noon on Monday with stocks from energy, industrials, financials and consumer sections posting impressive gains.
RTTNews
|
961 hari yang lalu
Summit Materials Says EVP And CFO Brian Harris Plans To Retire
Construction materials company Summit Materials, Inc. (SUM) announced Monday that Executive Vice President and Chief Financial Officer Brian Harris plans to retire after a decade with the Company.
RTTNews
|
961 hari yang lalu
European Markets Positive On Improved Sentiments
European stock markets are higher on Monday ahead of the crucial inflation data from the U.S. and improved global market sentiments. Asian market finished higher on the day. The U.K.'s FTSE 100 Index gaining 1.41 percent to 7,454.64, France's CAC 40 index is up 1.45 percent to 6,302.34, and German DAX is progressing 235.27 points or 1.8 percent to 13,323.48. The pan European Stoxx 600 is climbi
RTTNews
|
961 hari yang lalu
AmerisourceBergen To Buy Germany's PharmaLex Holding For EUR 1.28 Bln In Cash
AmerisourceBergen Corp. (ABC) announced Monday that it has signed a definitive agreement to acquire Germany's PharmaLex Holding GmbH, a leading provider of specialized services for the life sciences industry, from funds advised by AUCTUS Capital Partners AG for 1.28 billion euros in cash, subject to certain customary adjustments.
RTTNews
|
961 hari yang lalu
Horizon Says Phase 2 Trial Of Dazodalibep To Treat Sjögren's Syndrome Met Primary Endpoint
Horizon Therapeutics plc (HZNP) announced Monday that its Phase 2 trial evaluating dazodalibep for the treatment of Sjögren's syndrome met the primary endpoint in patients with moderate-to-high systemic disease activity. Sjögren's syndrome is a disease with no FDA-approved treatments available.
RTTNews
|
961 hari yang lalu
Stay up to date!
Add Berita to your browser
Add To Chrome
